Rick Dobin
Talk0this wiki
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology
Rick Doblin (born November 30, 1953) is the president and founder of the Multidisciplinary Association for Psychedelic Studies (MAPS).
He co-founded Earth Metabolic Design Laboratories in 1984 to support psychedelic research and Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986 with the goal of making MDMA (or Ecstasy) an FDA-approved medicine. He subsequently obtained a psychology degree from New College of Florida in 1987 and earned a doctorate in public policy from the Kennedy School of Government, Harvard University in 2001. Doblin also has served on the board of the National Organization for the Reform of Marijuana Laws since 1996.
In the early 1980s, Doblin owned and operated a company called Abraxas Construction, located in the Sarasota, Florida area, which specialized in relocating houses.
Writings
Edit
- Regulation of the Medical Use of Psychedelics and Marijuana [1]. A dissertation by Rick Doblin for his Ph.D. in Public Policy from the Kennedy School of Government, Harvard University. June 2001.
- Doblin, Richard and Kleiman, Mark A. R, "Marijuana as Antiemetic Medicine: A Survey of Oncologists' Experiences and Attitudes." Journal of Clinical Oncology. 1991; 9(7): pp. 1314-1319. [2]
ReferencesEdit
- The MAPS Staff
- Erowid character vaults
- Miliard, Mike: This is your brain on drugs: Rick Doblin thinks pot, ecstasy, and other psychedelics could unlock the human mind — and he wants to bring them to Harvard, the FDA, and a doctor’s office near you, The Boston Phoenix, Oct. 8-14, 2004.
- Frood, Arran : Interview: Keeping the psychedelic dream alive, New Scientist Magazine, 27 August 2008 issue 2671
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |
